Drug intelligence / Profile preview

saline + autologous plasma

Development stage
Unknown
Lead developer
Singapore National Eye Centre
Modality
Recombinant Proteins and Enzymes
Administration
Ophthalmic
01

Overview

Saline + autologous plasma is a therapeutic ophthalmic preparation used for the treatment of severe and recalcitrant dry eye disease. The formulation consists of plasma derived from the patient's own peripheral blood, which is typically diluted with sterile saline to concentrations such as 20% or 50%. This autologous biologic contains a concentrated array of essential components found in natural tears, including growth factors (such as EGF and TGF-β), fibronectin, vitamins, and immunoglobulins. These factors facilitate corneal epithelial wound healing, provide anti-inflammatory effects, and maintain the integrity of the ocular surface. By using the patient's own blood, the risk of immunological reactions or transmission of infectious diseases is minimized.

Other names
autologous plasma eye dropsautologous plasma exosome eye dropsautologous plasma preparation
02

Targets

Beyond the preview

Go deeper on saline + autologous plasma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on saline + autologous plasma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call